Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound

We report here on a chemical genetic screen designed to address the mechanism of action of a small molecule. Small molecules that were active in models of urinary incontinence were tested on the nematode Caenorhabditis elegans, and the resulting phenotypes were used as readouts in a genetic screen t...

Full description

Bibliographic Details
Main Authors: Fitzgerald, Kevin, Tertyshnikova, Svetlana, Moore, Lisa, Bjerke, Lynn, Burley, Ben, Cao, Jian, Carroll, Pamela, Choy, Robert, Doberstein, Steve, Dubaquie, Yves, Franke, Yvonne, Kopczynski, Jenny, Korswagen, Hendrik, Krystek, Stanley R, Lodge, Nicholas J, Plasterk, Ronald, Starrett, John, Stouch, Terry, Thalody, George, Wayne, Honey, van der Linden, Alexander, Zhang, Yongmei, Walker, Stephen G, Cockett, Mark, Wardwell-Swanson, Judi, Ross-Macdonald, Petra, Kindt, Rachel M
Format: Online
Language:English
Published: Public Library of Science 2006
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440875/
id pubmed-1440875
recordtype oai_dc
spelling pubmed-14408752006-05-08 Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound Fitzgerald, Kevin Tertyshnikova, Svetlana Moore, Lisa Bjerke, Lynn Burley, Ben Cao, Jian Carroll, Pamela Choy, Robert Doberstein, Steve Dubaquie, Yves Franke, Yvonne Kopczynski, Jenny Korswagen, Hendrik Krystek, Stanley R Lodge, Nicholas J Plasterk, Ronald Starrett, John Stouch, Terry Thalody, George Wayne, Honey van der Linden, Alexander Zhang, Yongmei Walker, Stephen G Cockett, Mark Wardwell-Swanson, Judi Ross-Macdonald, Petra Kindt, Rachel M Research Article We report here on a chemical genetic screen designed to address the mechanism of action of a small molecule. Small molecules that were active in models of urinary incontinence were tested on the nematode Caenorhabditis elegans, and the resulting phenotypes were used as readouts in a genetic screen to identify possible molecular targets. The mutations giving resistance to compound were found to affect members of the RGS protein/G-protein complex. Studies in mammalian systems confirmed that the small molecules inhibit muscarinic G-protein coupled receptor (GPCR) signaling involving G-αq (G-protein alpha subunit). Our studies suggest that the small molecules act at the level of the RGS/G-αq signaling complex, and define new mutations in both RGS and G-αq, including a unique hypo-adapation allele of G-αq. These findings suggest that therapeutics targeted to downstream components of GPCR signaling may be effective for treatment of diseases involving inappropriate receptor activation. Public Library of Science 2006-04 2006-04-21 /pmc/articles/PMC1440875/ /pubmed/16683034 http://dx.doi.org/10.1371/journal.pgen.0020057 Text en © 2006 Fitzgerald et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Fitzgerald, Kevin
Tertyshnikova, Svetlana
Moore, Lisa
Bjerke, Lynn
Burley, Ben
Cao, Jian
Carroll, Pamela
Choy, Robert
Doberstein, Steve
Dubaquie, Yves
Franke, Yvonne
Kopczynski, Jenny
Korswagen, Hendrik
Krystek, Stanley R
Lodge, Nicholas J
Plasterk, Ronald
Starrett, John
Stouch, Terry
Thalody, George
Wayne, Honey
van der Linden, Alexander
Zhang, Yongmei
Walker, Stephen G
Cockett, Mark
Wardwell-Swanson, Judi
Ross-Macdonald, Petra
Kindt, Rachel M
spellingShingle Fitzgerald, Kevin
Tertyshnikova, Svetlana
Moore, Lisa
Bjerke, Lynn
Burley, Ben
Cao, Jian
Carroll, Pamela
Choy, Robert
Doberstein, Steve
Dubaquie, Yves
Franke, Yvonne
Kopczynski, Jenny
Korswagen, Hendrik
Krystek, Stanley R
Lodge, Nicholas J
Plasterk, Ronald
Starrett, John
Stouch, Terry
Thalody, George
Wayne, Honey
van der Linden, Alexander
Zhang, Yongmei
Walker, Stephen G
Cockett, Mark
Wardwell-Swanson, Judi
Ross-Macdonald, Petra
Kindt, Rachel M
Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
author_facet Fitzgerald, Kevin
Tertyshnikova, Svetlana
Moore, Lisa
Bjerke, Lynn
Burley, Ben
Cao, Jian
Carroll, Pamela
Choy, Robert
Doberstein, Steve
Dubaquie, Yves
Franke, Yvonne
Kopczynski, Jenny
Korswagen, Hendrik
Krystek, Stanley R
Lodge, Nicholas J
Plasterk, Ronald
Starrett, John
Stouch, Terry
Thalody, George
Wayne, Honey
van der Linden, Alexander
Zhang, Yongmei
Walker, Stephen G
Cockett, Mark
Wardwell-Swanson, Judi
Ross-Macdonald, Petra
Kindt, Rachel M
author_sort Fitzgerald, Kevin
title Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
title_short Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
title_full Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
title_fullStr Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
title_full_unstemmed Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
title_sort chemical genetics reveals an rgs/g-protein role in the action of a compound
description We report here on a chemical genetic screen designed to address the mechanism of action of a small molecule. Small molecules that were active in models of urinary incontinence were tested on the nematode Caenorhabditis elegans, and the resulting phenotypes were used as readouts in a genetic screen to identify possible molecular targets. The mutations giving resistance to compound were found to affect members of the RGS protein/G-protein complex. Studies in mammalian systems confirmed that the small molecules inhibit muscarinic G-protein coupled receptor (GPCR) signaling involving G-αq (G-protein alpha subunit). Our studies suggest that the small molecules act at the level of the RGS/G-αq signaling complex, and define new mutations in both RGS and G-αq, including a unique hypo-adapation allele of G-αq. These findings suggest that therapeutics targeted to downstream components of GPCR signaling may be effective for treatment of diseases involving inappropriate receptor activation.
publisher Public Library of Science
publishDate 2006
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440875/
_version_ 1611381999253061632